I. Basics

Lee Elvin Sanghwan is a U.S.‐based activist investor noted for accumulating just over 6% of Salarius Pharmaceuticals in late 2023 and disclosing it via a Schedule 13D. Based out of Teaneck, NJ, he appears to hold a professional background in pharma quality/regulatory roles

II. Letters & Presentations

Nil

III. Significant companies
Below is a list of company engagements where the filer has filed a Schedule 13D and/or engaged in a proxy campaign. As the filer does not file a Form 13F, current ownership information is not available.